Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging
Status:
Recruiting
Trial end date:
2022-08-08
Target enrollment:
Participant gender:
Summary
OptiSkin is now enrolling a new study to monitor nail changes in patients with nail psoriasis
treated with Enbrel® (etanercept) with optical coherence tomography (OCT).